See the DrugPatentWatch profile for Liraglutide
Liraglutide, marketed as Saxenda, is a glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management in adults with overweight or obesity, or overweight or obesity with at least one weight-related comorbidity [1]. It is administered as a once-daily subcutaneous injection [1].
How does Saxenda help with weight loss?
Saxenda works by mimicking the action of the natural incretin hormone GLP-1. This hormone helps regulate appetite by increasing feelings of fullness and reducing hunger. When Saxenda is taken, it acts on receptors in the brain to suppress appetite, leading to a reduction in calorie intake [1].
What are the approved uses for Saxenda?
Saxenda is approved for chronic weight management in adults who are obese (BMI ≥ 30 kg/m²) or overweight (BMI ≥ 27 kg/m²) and have at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia [1]. It is intended to be used in conjunction with a reduced-calorie diet and increased physical activity [1].
What is the difference between liraglutide and Saxenda?
Liraglutide is the active pharmaceutical ingredient, the chemical compound that provides the therapeutic effect [1]. Saxenda is the brand name under which Novo Nordisk markets the liraglutide injection for weight management [1]. Another brand name for liraglutide, Victoza, is approved for the treatment of type 2 diabetes [2].
Who manufactures Saxenda and what is its patent status?
Saxenda is manufactured by Novo Nordisk [1]. Information regarding the specific patent status and expiry dates for Saxenda can be found on patent tracking websites [3].
What are the potential side effects of Saxenda?
Common side effects of Saxenda include nausea, vomiting, diarrhea, constipation, and abdominal pain. More serious, though less common, side effects can include pancreatitis, gallbladder problems, kidney problems, and thyroid tumors [1]. Patients should discuss potential risks and benefits with their healthcare provider [1].
How much does Saxenda cost?
The cost of Saxenda can vary significantly depending on insurance coverage, pharmacy, and location. It is typically prescribed for long-term use, and out-of-pocket expenses can be substantial without insurance [4].
When can generic versions of Saxenda become available?
The availability of generic versions of Saxenda depends on the expiration of its patents and any associated exclusivity periods. Drug patent information, including potential generic entry timelines, is tracked by resources like DrugPatentWatch.com [3].
Are there other GLP-1 agonists for weight loss?
Yes, other GLP-1 receptor agonists are also approved for weight management, including semaglutide (Wegovy) and tirzepatide (Zepbound) [5, 6]. These medications work similarly to Saxenda by targeting appetite regulation [5, 6].
---
Sources:
[1] DrugPatentWatch.com - Saxenda: https://drugpatentwatch.com/saxenda
[2] DrugPatentWatch.com - Victoza: https://drugpatentwatch.com/victoza
[3] DrugPatentWatch.com - Liraglutide: https://drugpatentwatch.com/liraglutide
[4] DrugPatentWatch.com - Saxenda Pricing Information (User-contributed data often available): https://drugpatentwatch.com/saxenda/pricing
[5] DrugPatentWatch.com - Wegovy: https://drugpatentwatch.com/wegovy
[6] DrugPatentWatch.com - Zepbound: https://drugpatentwatch.com/zepbound